This article is more than 5 years old. Information may no longer be current.
Lumify approval leads recent cornea news
The FDA’s approval of Lumify for ocular redness was the most-read recent cornea and external disease news, with international approvals also making headlines.
Here are five of the most-read recent cornea/external disease articles on Healio.com/OSN:
1. FDA approves Bausch + Lomb’s Lumify for treatment of eye redness
Lumify is the first over-the-counter eye drop developed with low-dose brimonidine tartrate for the treatment of ocular redness. Read more.
2. NovaTears+Omega-3 for evaporative dry eye approved in Europe
The first eye drop to have high concentrations of omega-3 (0.2%) ethyl ester of plant origin, NovaTears+Omega-3 stabilizes the lipid layer of the tear film and reduces evaporation of the underlying water phase of the tear film, supplementing the lipid layer with omega-3 fatty acids. Read more.
3. Mistletoe, carboxymethyl cellulose eye drops may relieve dry eye symptoms, signs
Mistletoe combined with carboxymethyl cellulose eye drops may ease the symptoms and signs of dry eye in postmenopausal women. Read more.
4. FDA accepts new drug application for Sun dry eye treatment
The FDA has accepted Sun Pharmaceutical Industries’ new drug application for OTX-101, an aqueous solution intended for treatment of dry eye disease. Read more.
5. Xiidra approved by Health Canada
Xiidra is the first new prescription medication to treat dry eye disease in Canada in 7 years. Read more.